CTRI/2020/01/022611已完成未知
STUDY OF LIPID PROFILE IN TREATMENT NAIVE HIV INFECTED PATIENTS
IRANJAN G M0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •CASES - TREATMENT NAIVE HIV INFECTED PATIENTS
- •CONTROL - AGE AND SEX MATCHED APPARENTLY HEALTHY INDIVIDUALS
排除标准
- •- HIV INFECTED INDIVIDUALS ON HAART TREATMENT
- •- INDIVIDUALS ON LIPID LOWERING DRUGS
- •- INDIVIDUALS WITH WITH PRE- EXISTING RENAL
- •DISEASES,DIABETES,LIVER DISORDER,THYROID
- •DISORDER AND SEPSIS
研究者
相似试验
已完成
不适用
HIV Disease and Impairment of High Density Lipoprotein MetabolismCardiovascular DiseaseACTRN12618000691246Baker Heart and Diabetes Instutite70
已完成
不适用
Changes in lipid profile in people living with HIV on stable protease inhibitors (PIs)-based regimens as second-line ART regimens switch to dolutegravir (DTG)-based regimenspeople living with HIVlipid profile, protease inhibitors, second-line ART regimens, switching, dolutegravirTCTR20240717004Faculty of Medicine, Chulalongkorn University144
Unknown
不适用
ipid profiles of HIV-infected patients with dyslipidemia after switching from efavirenz to dolutegravirDyslipidemiaHIVDyslipidemiaHIVTCTR20221118002Khon Kaen university64
招募中
4 期
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA 001)HIVMetabolic abnormalityLipodystrophyInfection - Acquired immune deficiency syndrome (AIDS / HIV)Cardiovascular - Other cardiovascular diseasesCardiovascular diseaseACTRN12605000662662The University of New South Wales80
已完成
3 期
A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenHIV InfectionsNCT00135395Bristol-Myers Squibb200